**UNITED
      STATES**


**SECURITIES
      AND EXCHANGE COMMISSION**


Washington,
      DC 20549





**FORM
        10-QSB/A**





[X]
            Quarterly
                Report pursuant to Section 13 or 15(d) of the Securities Exchange
                Act of
                1934For
                the quarterly period endedFebruary
                28, 2007[
                ]
            Transition
                Report pursuant to 13 or 15(d) of the Securities Exchange Act of
                1934For
                the transition period __________to__________Commission
                File Number:333-140438





RM
      Health International, Inc.


(Exact
      name of small business issuer as specified in its charter)





Nevada
            Applied
                For(State
                or other jurisdiction of incorporation or
                organization)
            (IRS
                Employer Identification No.)




36
                Palazzo Terrace, Henderson, NV 89074(Address
                of principal executive offices)





(702)
                612-3014(Issuer’s
                telephone number)_______________________________________________________________(Former
                name, former address and former fiscal year, if changed since last
                report)





Check
      whether the issuer (1) filed all reports required to be filed by Section 13
      or
      15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
      (or
      for such shorter period that the issuer was required to file such reports),
      and
      (2) has been subject to such filing requirements for the past 90 days [X] Yes
      [
      ] No





Indicate
      by check mark whether the registrant is a shell company (as defined in Rule
      12b-2 of the Exchange Act). [X] Yes [ ] No





State
      the
      number of shares outstanding of each of the issuer’s classes of common stock, as
      of the latest practicable date: 6,759,300 common shares as of April 16,
      2007





Transitional
      Small Business Disclosure Format (check one): Yes [ ] No [X]







**Explanatory
          Note**
  The
          purpose of this Amendment No. 1 to the Quarterly Report on Form 10-QSB
          previously filed with the United States Securities and Exchange Commission
          on April 17, 2007, is to revise the Note 1 to the Interim Financial
          Statements.


Table
          of Contents


TABLE
                OF CONTENTS
            PagePART
                I - FINANCIAL INFORMATIONItem
                1.
            Financial
                Statements
            3Item
                2.
            Plan
                of Operation
            4Item
                3.
            Controls
                and Procedures
            14PART
                II - OTHER INFORMATIONItem
                1.
            Legal
                Proceedings
            15Item
                2.
            Unregistered
                Sales of Equity Securities and Use of
                Proceeds
            15Item
                3.
            Defaults
                Upon Senior Securities
            15Item
                4.
            Submission
                of Matters to a Vote of Security
                Holders
            15Item
                5.
            Other
                Information
            15Item
                6.
            Exhibits
            15


2
 Table
          of Contents


**PART
      I - FINANCIAL INFORMATION**





**Item1.**  **Financial
      Statements**





Our
                unaudited financial statements included in this Form 10-QSB are as
                follows:F-1
            Balance
                Sheet as of February 28, 2007;F-2
            Statements
                of Operations for the three months ended February
                28, 2007 (unaudited);F-3
            Statements
                of Cash Flows for the three months ended February
                28, 2007 (unaudited);F-4
            Notes
                to Financial
                Statements;








These
      unaudited financial statements have been prepared in accordance with accounting
      principles generally accepted in the United States of America for interim
      financial information and the SEC instructions to Form 10-QSB. In the opinion
      of
      management, all adjustments considered necessary for a fair presentation have
      been included. Operating results for the interim period ended February 28,
      2007
      are not necessarily indicative of the results that can be expected for the
      full
      year.


3
 Table
          of Contents


**RM
        HEALTH INTERNATIOINAL, INC.**
 (A
        Development Stage Company)
 BALANCESHEET
 (Stated
        in US Dollars)
 
 February
                    28,
                  2007
              
              November
                    30,
                  2006(Unaudited)
              
              (Audited)**ASSETS**CurrentCash
              $
              19,490
              
              $
              23,995Prepaid
                  expenses
              
              225
              
              
              -$
              19,715
              
              $
              23,995**LIABILITIES**CurrentAccounts
                  payable and accrued liabilities
              $
              3,950
              
              $
              3,650Due
                  to related party - Note 4
              
              4,125
              
              
              3,0008,075
              
              
              6,650**STOCKHOLDERS’
                  EQUITY**Capital
                  stock - Note 375,000,000
                  shares authorized, $0.001 par value6,759,300
                  shares issued and outstanding
              
              6,759
              
              
              6,759Additional
                  paid-in capital
              
              20,926
              
              
              20,926Deficit
                  accumulated during the development stage
              
              (16,045)
              
              
              (10,340)11,640
              
              
              17,345$
              19,715
              
              $
              23,995Nature
                and Continuance of Operations - Note
                1
  The accompanying notes are an integral
        part of
        these financial statements.
 F-1
 Table
            of Contents
 **RM
        HEALTH INTERNATIOINAL, INC.**
 (A
        Development Stage Company)
 INTERIM
        STATEMENTOF OPERATIONS
 (Stated
        in US Dollars)
 (Unaudited)
 
 Three
                        months
                      Ended
                      February
                        28,
                      2007
              
              March
                        28, 2006
                      (Inception)
                      to
                        February 28,
                      2007ExpensesAccounting
                  and audit fees
              $
              2,100
              
              $
              8,000Consulting
              
              2,000
              
              
              2,000General
                  and Administrative
              
              480
              
              
              795Legal
              
              -
              
              
              750Organization
                  costs
              
              -
              
              
              375Rent
              
              1,125
              
              
              4,125Net
                  loss for the period
              $
              (5,705)
              
              $
              (16,045)Basic
                  loss per share
              $
              (
                  0.001)Weighted
                  average number of shares outstanding
              
              6,759,300
  The accompanying notes are an integral
        part of
        these financial statements.
 F-2
 Table
            of Contents
 **RM
        HEALTH INTERNATIOINAL, INC.**
 (A
        Development Stage Company)
 INTERIM
        STATEMENT OF CASHFLOWS
 (Stated
        in US Dollars)
 (Unaudited)
 
 Three
                        months
                      Ended
                      February
                        28,
                      2007
              
              March
                        28, 2006
                      (Inception)
                      to
                        February 28,
                      2007Operating
                  ActivitiesNet
                  loss for the period
              $
              (5,705)
              
              $
              (16,045)Change
                  in non-cash working capital itemsAccounts
                  payable and accrued liabilities
              
              300
              
              
              3,950(5,405)
              
              
              (12,095)Financing
                  ActivitiesIncrease
                  in due to related party
              
              1,125
              
              
              4,125Proceeds
                  from issuance of common stock
              
              -
              
              
              27,6851,125
              
              
              31,810Increase
                  (decrease) in cash during the period
              
              (4,280)
              
              
              19,715Cash,
                  beginning of the period
              
              23,995
              
              
              -Cash,
                  end of the period
              $
              19,715
              
              $
              19,715Supplementary
                disclosure of cash flow information:Cash
                paid for:Interest
              $
              -
              
              $
              -Income
                Taxes
              $
              -
              
              $
              -
  The
        accompanying notes are an integral part of these
        financial statements.
 F-3
 Table
            of Contents
 **RM
        HEALTH INTERNATIOINAL, INC.**
 (A
        Development Stage Company)
 NOTESTO
        THE INTERIM FINANCIAL STATEMENTS
 February
        28, 2007
 (Stated
        in US Dollars)
 (Unauidted)
 
 
 Note 1
              Nature
                  and Continuance of Operations
 *Organization*
  The
            Company was incorporated in the State of Nevada, United States of America
            on
            March 28, 2006 and its fiscal year end is November 30. The Company is
            involved
            in sales and distribution of natural health and supplemental products
            through
            Internet.
  *Going
            concern*
  These
            financial statements have been prepared on a going concern basis which
            assumes
            that the Company will be able to realize its assets and discharge its
            liabilities in the normal course of business. The Company has incurred
            losses
            since inception resulting in an accumulated deficit of $16,045 as of
            February
            28, 2007, and further losses are anticipated in the development of its
            business
            raising substantial doubt about the Company’s ability to continue as a going
            concern. These financial statements do not include any adjustments to
            the
            amounts and classifications of assets and liabilities that might be necessary
            should the Company be unable to continue as a going
            concern.
  *Unaudited
            Interim Financial Statements*
  The
            accompanying unaudited interim financial statements have been prepared
            in
            accordance with United States generally accepted accounting principles
            for
            interim financial information and with the instructions to Form 10-QSB
            of
            Regulation S-B. Certain information and footnote disclosures normally
            included
            in financial statements prepared in accordance with accounting principles
            generally accepted in the United States of America have been condensed
            or
            omitted pursuant to such rules and regulations. However, except as disclosed
            herein, there have been no material changes in the information disclosed
            in the
            notes to the financial statements for the year ended November 30, 2006
            included
            in the Company’s SB-2 filed with the Securities and Exchange Commission. The
            interim unaudited financial statements should be read in conjunction
            with those
            financial statements included in the Form SB-2. In the opinion of Management,
            all adjustments considered necessary for a fair presentation, consisting
            solely
            of normal recurring adjustments, have been made. Operating results for
            the three
            months ended February 28, 2007 are not necessarily indicative of the
            results
            that may be expected for the year ending November 30,
            2007.
  F-4
 Table
            of Contents
 
 Note 2
              Capital
                  Stock
 
 The
        total
        number of common shares authorized that may be issued by the Company is
        75,000,000 shares with a par value of one tenth of one cent ($0.001) per
        share
        and no other class of shares is authorized.
 
 During
        the period from March 28, 2006 (Inception) to November 30, 2006, the Company
        issued 6,759,300 shares of common stock for total proceeds of
        $27,685.
 
 To
        February 28, 2007, the Company has not granted any stock options and has
        not
        recorded any stock-based compensation.
 
 Note
                  3
              Related
                  Party Transactions
  The
        President of the Company provides office rent to the Company. The rent is
        valued
        at $375 per month. During the period ended February 28, 2007 office rent
        of
        $1,125 (November 30, 2006 - $3,000) was charged to operations.


F-5
 Table
          of Contents




**Item2.     Plan
      of
      Operation**





**Forward-Looking
      Statements**





Certain
      statements, other than purely historical information, including estimates,
      projections, statements relating to our business plans, objectives, and expected
      operating results, and the assumptions upon which those statements are based,
      are “forward-looking statements” within the meaning of the Private Securities
      Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933
      and Section 21E of the Securities Exchange Act of 1934. These
      forward-looking statements generally are identified by the words “believes,”
“project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,”
“may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and
      similar expressions. We
      intend
      such forward-looking statements to be covered by the safe-harbor provisions
      for
      forward-looking statements contained in the Private Securities Litigation Reform
      Act of 1995, and are including this statement for purposes of complying with
      those safe-harbor provisions. Forward-looking
      statements are based on current expectations and assumptions that are subject
      to
      risks and uncertainties which may cause actual results to differ materially
      from
      the forward-looking statements. Our
      ability to predict results or the actual effect of future plans or strategies
      is
      inherently uncertain. Factors which could have a material adverse affect on
      our
      operations and future prospects on a consolidated basis include, but are not
      limited to: changes in economic conditions, legislative/regulatory changes,
      availability of capital, interest rates, competition, and generally accepted
      accounting principles. These risks and uncertainties should also be considered
      in evaluating forward-looking statements and undue reliance should not be placed
      on such statements. We
      undertake no obligation to update or revise publicly any forward-looking
      statements, whether as a result of new information, future events or otherwise. Further
      information concerning our business, including additional factors that could
      materially affect our financial results, is included herein and in our other
      filings with the SEC.





**Overview**





We
      were
      incorporated on March 28, 2006 as RM Health International, Inc., a Nevada
      corporation, and we do business under the name “R&M Online Health.” R&M
      Online Health plans to provide a comprehensive education resource and online
      purchase facility. The education component is an important part of the marketing
      plan as the need for consumer education in the marketplace is evident. Finding
      the optimal balance of price, benefits and levels of understanding drive
      consumer choice among natural and organic products and provides an edge over
      conventional methods of retail sales.





The
      R&M Online Health business model is based on creating a web based storefront
      and education center targeted at the Lifestyles of Health and Sustainability
      (“LOHAS”) consumers LOHAS demographic. Custom content is offered to attract
      traffic to the site. Purchase options presented are based on the education
      content for specific conditions or categories. R&M Online is the conduit
      that brings together the independent groups of customers, providers, advertisers
      and affiliates. R&M Online Health creates reseller and private label
      agreements with specific providers and suppliers who meet our criteria. R&M
      receives a profit on each order from the




4
 Table
          of Contents




R&M
      site or its affiliates. Orders are processed through the R&M site and
      transaction engine then sent to the supplier who provisions (drop ships) the
      order directly to the customer. R&M Online will create a membership program
      that will encourage customer loyalty with expanded benefits and programs. Since
      the R&M consumer is concerned with lifestyle issues there are multiple
      opportunities for R&M to create relationships and generate revenue from
      advertisers and affiliates such as Gaiam.com. R&M is not limited in the
      number of relationships that can be created. Advertising value will be driven
      as
      traffic to the site increases and the size of the membership database
      increases.





**Principal
      Products and Services**





These
      are
      the top 20 sales categories of products and supplements. R&M Online will
      focus its efforts on locating and offering for sale superior products within
      the
      following specific categories:





1.
      Cleanse.


2.
      Digestive and Gastronomical Aids.


3.
      Diabetes management.


4.
      Immune
      System support.


5.
      Bone
      and Joint (Osteoporosis and Arthritis).


6.
      Circulatory System.


7.
      Natural products for appearance.


8.
      Concentration.


9.
      Sports
      and Fitness.


10.
      Weight Management and control.


11.
      Respiratory System.


12.
      Glandular System.


13.
      Stress Management aids.


14.
      Prostate Support.


15.
      Women’s Health and Support.


16.
      Increased Energy and Fatigue.


17.
      Bowl
      elimination and support.


18.
      Improving Sexual performance Male and Female.


19.
      Improving Cardiovascular Health.


20.
      Controlling Blood pressure and blood sugar support.





Supplemental
      products - b ooks
      and
      CD’s on health and lifestyle.





Since
      the
      consumer searches for products by benefit, the navigation for the site will
      be
      built around these benefits. Since some products have multiple benefits the
      consumer will be offered program choices. At each product selection they will
      be
      given a one off non-member price, member price, and automatic recurring price.
      Each particular benefit category will also come with the appropriate information
      on the product, trends, and other lifestyle suggestions for improvement.
      Complimentary products will also be suggested according to the benefit
      profile.





The
      R&M Online site is designed to be simple to navigate identifying the two
      types of visitors to




5
 Table
          of Contents




the
      site,
      new visitors, and existing members. New visitors will be initially directed
      to
      membership area where they can sign up for the free membership or premium (pay).
      Existing members are taken straight to their account information, preferences
      and order profile.





Customers
      are never more than a single click away from being able to order products,
      refer
      their friends and associates or join the membership program. The operating
      goal
      of the site is to have each and every visitor participate in one form or another
      either by ordering product or becoming part of the database asset.





**Initial
      Product Line**





R&M
      Online is not restricted to any one particular product line which leaves the
      company free to offer the best product in each category of consumer interest.
      R&M Online does extensive research on each and every product for efficacy
      and benefits. Only category leaders are offered in the R&M Online portfolio.
      The following companies will serve as the suppliers of our initial product
      line:





**Ayush
      Herbs, Inc. -** The
      company provides the highest quality of herbal products, vitamins, minerals
      and
      enzymes available. All the products are naturally grown in the Himalayan habitat
      without the use of pesticides and other chemicals.




**Cyto-Matrix,
      Inc. -** Cyto-Matrix
      strives to improve the health and wellbeing of its customers by using the
      highest quality of raw materials and manufacturing products in a
      state-of-the-art manufacturing facility.





Our
      initial product line will include the following natural remedies:





**(1)**  **High
      blood pressure remedy**





**Product
      Name:**   Carditone


**Retail
      Price**    $28.00





**Description:**  Carditone
      contains the herb Rauwolfia serpentina, which has become an important
      therapeutic aid to promote healthy blood pressure. It has strong hypotensive
      and
      sedative activity. Arjuna and rose powder have been used for centuries in
      Ayurveda to support heart function, while Tribulus terrestris is considered
      renal supportive. Indian coral powder is a good source of calcium and
      magnesium.





**Attributes:**   Vegetarian





**Ingredients:**  Standardized
      extract of Rauwolfia serpentina, Arjuna, Convovulus plericaulis, Tribulus
      terrestris, and Magnesium aspartate in a base of rose powder, Boerhaavia diffusa
      and Indian coral powder. Amount per tablet: Convolvuvus P 100mg, Arjuna 100mg,
      Tribulus T 100mg, Rauwolfia 50mg





**Dosage:**  One
      tablet 2 times daily or as directed by physician





6
 Table
          of Contents




**(2)**  **High
      cholesterol remedy**





**Product
      Name:**   Lipo
      matrix


**Retail
      Price:**    $35.99





**Description:**  This
      new
      Lipo-Matrix formulation is a unique blend of botanicals and vitamins with high
      grade-level evidence specifically focused on cardiovascular disease. The
      ingredients and dosages have been carefully chosen to reflect the current
      evidence in cardiovascular disease


management.





**Ingredients:**   For
      decreasing hyperlipidemia: Policosanol; Guggul Resin Extract; Raw Garlic
      Extract; Inositol hexaniacinate. For decreasing hyperhomocysteinemia: Folic
      Acid; Vitamin B6; Vitamin B12. For increasing HDL: Policosanol; Inositol
      hexaniacinate. For cardiovascular secondary prevention: Inositol hexaniacinate;
      Policosanol; Raw Garlic Extract





**Dosage:**  As
      recommended by your health care provider





**(3)**  **Women's
      health - menopause**





**Product
      Name:**   Eleg
      fem


**Retail
      Price:**    $27.50





**Description:**  ElegFemTM
      is especially helpful for pre-menopausal and menopausal conditions. The
      synergistic action of Ashoka, Dioscorea, Asparagus, Arjuna, Cissus
      quadrangularis and Indian coral powder has been shown to alleviate symptoms
      associated with menopause. Coral powder is a rich source of calcium and
      magnesium. Cissus quadrangularis traditionally has been used to speed the
      healing process of bone fractures.





**Attributes:**   Vegetarian





**Ingredients:**   Ashoka,
      Dioscorea, Asparagus, Arjuna, Cissus quadrugularis,


Bamboo
      manna and Indian coral powder.





**Dosage:**  One
      Capsule 3 times a day or as directed by your physician





**(4)**  **Women's
      health - PMS**





**Product
      Name:**   Fem
      matrix


**Retail
      Price:**    $46.99





**Description:**  The
      herbs
      used in Fem-Matrix have a long history of use for the prevention and treatment
      of menopausal and perimenopausal symptoms, mainly hot flushes. While Black
      Cohosh, Dong Quai, Chasteberry, Wild Yam, and Red Clover




7
 Table
          of Contents




extracts
      have estrogen-like effects, Hesperidin and Quercetin reduces the loss of
      endogenous estrogen, which is associated with the symptoms.





**Ingredients:**  Black
      Cohosh, Dong Quai, Chasteberry, Wild Yam, Red Clover, Hesperidin and
      Quercetin





**Dosage:**  As
      recommended by your physician





**(5)**  **Sexual
      Vitality Female**





**Product
      Name:**   Purush


**Retail
      Price:**    $27.50 ****





**Description:**  Purush
      is
      a combination of Ayurvedic herbal aphrodisiacs based on the ancient use of
      these
      herbs to support male sexual health. Ashwagandha helps the body to slow down
      cellular aging and to combat fatigue; the anti-oxidant Amla provides energy
      and
      vigor; Tribulus has been shown to increase testosterone levels and Shilajeet
      is
      a mineral compound that boosts physical stamina and strengthens bone tissue.
      PurushTM also contains Yohimbe, which has been traditionally used to promote
      normal sexual function.





**Attributes:**   Vegetarian





**Ingredients:**   Standardized
      extracts of Ashwagandha 175mg, Macuna pruriens 20mg, Tribulus terrestis 50mg,
      Shilajit 25mg, Saw Palmeto 25mg, Saffron, Amla, Shilajeet, Pippli, Licorice,
      Bacopa monnieri, Bala talmakhana, Akarkara, Muira puma, Colchicum and
      Yohimbe





**Dosage:**  As
      recommended by your physician





**(6)**  **Male
      vitality - Remedy**





**Product
      Name:**   Purush


**Retail
      Price:**    $27.50





**Description:**  Purush
      is
      a combination of Ayurvedic herbal aphrodisiacs based on the ancient use of
      these
      herbs to support male sexual health. Ashwagandha helps the body to slow down
      cellular aging and to combat fatigue; the anti-oxidant Amla provides energy
      and
      vigor; Tribulus has been shown to increase testosterone levels and Shilajeet
      is
      a mineral compound that boosts physical stamina and strengthens bone tissue.
      PurushTM also contains Yohimbe, which has been traditionally used to promote
      normal sexual function.





**Attributes:**   Vegetarian





**Ingredients:**   Standardized
      extracts of Ashwagandha 175mg, Macuna pruriens 20mg,




8
 Table
          of Contents




Tribulus
      terrestis 50mg, Shilajit 25mg, Saw Palmeto 25mg, Saffron, Amla,


Shilajeet,
      Pippli, Licorice, Bacopa monnieri, Bala talmakhana, Akarkara,


Muira
      puma, Colchicum and Yohimbe





**Dosage:**   Two
      Capsules at bedtime or 1 Capsule twice a day - Do not exceed 6 capsules a day.
      Discontinue 1 week after every 10 to 12 weeks, or use as directed by your
      physician.





Both
      in
      initial and repeat traffic to the R&M Online site will be driven by the
      site’s educational content tailored to various specific conditions and health
      needs.





**Marketing
      Plan**





There
      are
      two components to the marketing plan. The first is the external focus to attract
      customers and drive traffic to the site. The second to create membership,
      loyalty and referral programs once the consumer has arrived at the
      site.





**External
      Marketing**





R&M
      will focus most of the external marketing efforts on search engine optimization,
      with specific efforts focused on the characteristics of Google the most popular
      and successful search engine. The dynamics of search engine optimization (SEO)
      have changed dramatically in the last few years. In the early 2000’s, search
      engines have veered away from reliance on meta tags since many web sites used
      inappropriate meta keywords or a technique known as keyword stuffing, in order
      to increase their search engine ranking. Some search engines still take meta
      tags into consideration when delivering results, though most of the major search
      engines ignore them. Organic search engines such as Google and Yahoo now use
      up
      to 100 different criteria to rank the listings on it’s search engine results
      pages (SERP’s). In order to achieve prime results on the SERP’s R&M will
      purchase Google Adwords and links from partner affiliate sites that ensure
      strong positioning in our niche market. In contrast, many businesses try to
      optimize their sites for large numbers of highly specific keywords that indicate
      readiness to buy. Overly broad search optimization can hinder marketing strategy
      by generating a large volume of low-quality inquiries that cost money to handle,
      yet result in little business. Focusing on desirable traffic generates better
      quality sales leads, resulting in more sales. Search engine optimization can
      be
      very effective when used as part of a smart niche marketing strategy.





**Referral
      Program**





R&M
      Online customers receive ongoing incentives to refer their friends and
      associates to the


site.
      It
      is important to keep in mind that particularly with LOHAS consumers since they
      are “values” driven they tend to share information within their community of
      associates. Customers will receive incentives to refer their friends directly
      at
      the site and from informational emails they receive from R&M
      Online.





9
 Table
          of Contents





**Membership
      Program**





All
      visitors to the R&M Online site will be given incentives to join a
      membership program. This is a very valuable demographic so acquiring additional
      information to build the database will


become
      a
      company asset.





**Automatic
      Order Renewals**





One
      of
      the keys to beginning any new lifestyle regimen is maintaining consistency
      and
      developing a habit. One of the options of membership to R&M Online is
      automatic order renewals that save the customer time and money. Renewal options
      are offered in 3, 6, and 12 month increments. The longer the extension of the
      program the greater the discount the customer receives. It is anticipated this
      program will be very popular since customers are making a lifestyle commitment
      and not a one off purchase.





**Survey
      Tool**





Most
      sites currently available on the internet are just basic virtual storefronts,
      some with limited


information.
      R&M Online will be far more interactive by using a survey tool that will
      help direct


customers
      to the products and supplements based suited for them based on lifestyle
      questions.





**Operating
      Budget**





For
      the
      fiscal year beginning November 30, 2006





Rent
            $
            375.00Legal
            $
            4,800.00Accounting
            $
            4,500.00Product
              procurement
            $
            1,200.00Business
              Plan
            $
            1,100.00Website
              Development
            $
            4,600.00Advertising
            $
            3,600.00$
            20,175.00




**Operating
      Objectives For The Fiscal Year Beginning November 30, 2006**





During
      the first and second quarters of our first full fiscal year, we will focus
      on
      acquiring various private label brands and other unique products to give us
      a
      necessary competitive advantage as well as developing our website and related
      infrastructure and establishing our initial network of advertisers and
      affiliates. During the third quarter, we expect to focus heavily on the
      development of our website while continuing to build our network of advertisers
      and affiliates. We plan to go online with our website and begin experiencing
      revenue by end of the fiscal year. The following is a schedule of our business
      development goals for the current fiscal year:





10
 Table
          of Contents





**By
                end of second quarter:**
            1
                to 3 future website advertiser/ affiliate relationships established;
                advanced discussions regarding supply agreement for some private
                label
                products to be offered on the website in addition to planned brand-name
                products; website development underway**By
                end of third quarter:**
            4
                to 6 total website advertiser/ affiliate relationships established;
                supply
                agreement reached regarding private label products; website development
                in
                beta testing**By
                end of fourth quarter:**
            RM
                Online Health website online; sales revenues
                begin





**Expected
      Changes In Number of Employees, Plant, and Equipment**





We
      do not
      have plans to purchase any physical plant or any significant equipment or to
      change the number of our employees during the next twelve months.





**Results
      of Operations for the three months ended February 28, 2007**





We
      did
      not earn any revenues from inception through the period ending February 28,
      2007. We do not anticipate earning revenues until active operation of our web
      site is launched in the fourth quarter of the fiscal year beginning November
      30,
      2006. We are presently in the development stage of our business and we can
      provide no assurance that we will produce significant revenues from the sale
      of
      our products on the Internet or from advertising on our website, or if revenues
      are earned, that we will be profitable.





We
      incurred operating expenses in the amount of $5,705 from our inception on March
      28, 2006 through period ending February 28, 2007. Our operating expenses from
      inception through February 28, 2007 included office, rent and administration
      expenses in the amount of $1,605 and accounting and consulting costs in the
      amount of $4,100. We anticipate our operating expenses will increase as we
      undertake our plan of operations. The increase will be attributable to
      undertaking development of our website and related activities and the
      professional fees associated with our becoming a reporting company under the
      Securities Exchange Act of 1934.





**Liquidity
      and Capital Resources**





As
      of
      February 28, 2007, we had cash of $19,490 and working capital of $11,460. Our
      cash on hand will allow us to cover our anticipated expenses for the fiscal
      year
      beginning November 30, 2006, but will not be sufficient to fund operations
      beyond the current fiscal year and will not be sufficient to pay any significant
      unanticipated expenses. We currently do not have any operations and we have
      no
      income. We will require additional financing to sustain our business operations
      if we are not successful in earning substantial revenues within the fiscal
      year
      beginning November 30, 2006.




11
 Table
          of Contents




We
      currently do not have any arrangements for financing and we may not be able
      to
      obtain financing when required.





We
      have
      not attained profitable operations and may be dependent upon obtaining financing
      to pursue our long-term business plan. For these reasons our auditors stated
      in
      their report that they have substantial doubt we will be able to continue as
      a
      going concern.





**Off
      Balance Sheet Arrangements**





As
      of
      February 28, 2007, there were no off balance sheet arrangements.





**Going
      Concern**




Our
      financial statements have been prepared on a going concern basis. We have a
      working capital of $11,640 as of February 28, 2007 and have accumulated deficit
      of $16,045 since inception. Our ability to continue as a going concern is
      dependent upon our ability to generate profitable operations in the future
      and/or to obtain the necessary financing to meet our obligations and repay
      our
      liabilities arising from normal business operations when they come due. The
      outcome of these matters cannot be predicted with any certainty at this time.
      These factors raise substantial doubt that we will be able to continue as a
      going concern. Management plans to continue to provide for our capital needs
      by
      the issuance of common stock and related party advances.





**Critical
      Accounting Policies**





In
      December 2001, the SEC requested that all registrants list their most “critical
      accounting polices” in the Management Discussion and Analysis. The SEC indicated
      that a “critical accounting policy” is one which is both important to the
      portrayal of a company’s financial condition and results, and requires
      management’s most difficult, subjective or complex judgments, often as a result
      of the need to make estimates about the effect of matters that are inherently
      uncertain. There are no critical accounting policies for the company as this
      time.





**Recently
      Issued Accounting Pronouncements**





In
      February 2006, the FASB issued SFAS No. 155, “Accounting for Certain Hybrid
      Financial Instruments-an amendment of FASB Statements No. 133 and 140”, to
      simplify and make more consistent the accounting for certain financial
      instruments. SFAS No. 155 amends SFAS No. 133, “Accounting for Derivative
      Instruments and Hedging Activities”, to permit fair value remeasurement for any
      hybrid financial instrument with an embedded derivative that otherwise would
      require bifurcation, provided that the whole instrument is accounted for on
      a
      fair value basis. SFAS No. 155 amends SFAS No. 140, “Accounting for the
      Impairment or Disposal of Long-Lived Assets”, to allow a qualifying
      special-purpose entity to hold a derivative financial instrument that pertains
      to a beneficial interest other than another derivative financial instrument.
      SFAS No. 155 applies to all financial instruments acquired or issued after
      the
      beginning of an




12
 Table
          of Contents




entity's
      first fiscal year that begins after September 15, 2006, with earlier application
      allowed. This standard is not expected to have a significant effect on our
      future reported financial position or results of operations.




In
      March
      2006, the FASB issued SFAS No. 156, "Accounting for Servicing of
      Financial Assets, an amendment of FASB Statement No. 140, Accounting for
      Transfers and Servicing of Financial Assets and Extinguishments of
      Liabilities". This statement requires all separately recognized servicing
      assets and servicing liabilities be initially measured at fair value, if
      practicable, and permits for subsequent measurement using either fair value
      measurement with changes in fair value reflected in earnings or the amortization
      and impairment requirements of Statement No. 140. The subsequent measurement
      of
      separately recognized servicing assets and servicing liabilities at fair value
      eliminates the necessity for entities that manage the risks inherent in
      servicing assets and servicing liabilities with derivatives to qualify for
      hedge
      accounting treatment and eliminates the characterization of declines in fair
      value as impairments or direct write-downs. SFAS No. 156 is effective
      for an entity's first fiscal year beginning after September 15,
      2006.  Management is currently evaluating the impact, which the
      adoption of this standard will have on our financial
      statements.





In
      June
      2006, the FASB issued FASB Interpretation Number 48, "Accounting for Uncertainty
      in Income Taxes - an interpretation of FASB Statement No. 109."  This
      Interpretation clarifies the accounting for uncertainty in income taxes
      recognized in an enterprise's financial statements in accordance with FASB
      Statement No. 109, "Accounting for Income Taxes."  This Interpretation is
      effective for fiscal years beginning after December 15, 2006. We are currently
      assessing the effect of this Interpretation on its financial
      statements.


13
 Table
          of Contents


**Item3.     Controls
      and Procedures**





We
      carried out an evaluation of the effectiveness of the design and operation
      of
      our disclosure controls and procedures (as defined in Exchange Act Rules
      13a-15(e) and 15d-15(e)) as of February 28, 2007. This evaluation was carried
      out under the supervision and with the participation of our Chief Executive
      Officer and our Chief Financial Officer, Mr. Randy Weston. Based upon that
      evaluation, our Chief Executive Officer and Chief Financial Officer concluded
      that, as of February 28, 2007, our disclosure controls and procedures are
      effective. There have been no changes in our internal controls over financial
      reporting during the quarter ended February 28, 2007.





Disclosure
      controls and procedures are controls and other procedures that are designed
      to
      ensure that information required to be disclosed in our reports filed or
      submitted under the Exchange Act are recorded, processed, summarized and
      reported, within the time periods specified in the SEC's rules and forms.
      Disclosure controls and procedures include, without limitation, controls and
      procedures designed to ensure that information required to be disclosed in
      our
      reports filed under the Exchange Act is accumulated and communicated to
      management, including our Chief Executive Officer and Chief Financial Officer,
      to allow timely decisions regarding required disclosure.





Limitations
      on the Effectiveness of Internal Controls





Our
      management does not expect that our disclosure controls and procedures or our
      internal control over financial reporting will necessarily prevent all fraud
      and
      material error. Our disclosure controls and procedures are designed to provide
      reasonable assurance of achieving our objectives and our Chief Executive Officer
      and Chief Financial Officer concluded that our disclosure controls and
      procedures are effective at that reasonable assurance level. Further, the design
      of a control system must reflect the fact that there are resource constraints,
      and the benefits of controls must be considered relative to their costs. Because
      of the inherent limitations in all control systems, no evaluation of controls
      can provide absolute assurance that all control issues and instances of fraud,
      if any, within the Company have been detected. These inherent limitations
      include the realities that judgments in decision-making can be faulty, and
      that
      breakdowns can occur because of simple error or mistake. Additionally, controls
      can be circumvented by the individual acts of some persons, by collusion of
      two
      or more people, or by management override of the internal control. The design
      of
      any system of controls also is based in part upon certain assumptions about
      the
      likelihood of future events, and there can be no assurance that any design
      will
      succeed in achieving its stated goals under all potential future conditions.
      Over time, control may become inadequate because of changes in conditions,
      or
      the degree of compliance with the policies or procedures may deteriorate.


14
 Table
          of Contents


**PART
      II - OTHER INFORMATION**





**Item1.     Legal
      Proceedings**





We
      are
      not a party to any pending legal proceeding. We are not aware of any pending
      legal proceeding to which any of our officers, directors, or any beneficial
      holders of 5% or more of our voting securities are adverse to us or have a
      material interest adverse to us.





**Item
      2.     Unregistered Sales of Equity
      Securities and Use of Proceeds**





On
      February 22, 2007, the registration statement filed on Form SB-2 (Commission
      file number 333-140438) was declared effective by the SEC. This offering has
      commenced and is ongoing. This registration statement registered 3,559,300
      shares of Common Stock on behalf of certain selling shareholders of the company.
      We will not receive any proceeds from this offering and have not made any
      arrangements for the sale of these securities.





**Item3.     Defaults
      upon Senior
      Securities**





None





**Item4.     Submission
      of Matters to a Vote
      of Security Holders**





No
      matters have been submitted to our security holders for a vote, through the
      solicitation of proxies or otherwise, during the quarterly period ended February
      28, 2007.





**Item5.     Other
      Information**





None





**Item6.      Exhibits**





**Exhibit****Number**
            **Description
                of Exhibit**3.1
            Articles
                of Incorporation(1)3.2
            By-Laws(1)31.1
            Certification
                of Chief Executive Officer pursuant to 18
                U.S.C. Section 1350, as adopted pursuant to Section 302 of the
                Sarbanes-Oxley Act of 200231.2
            Certification
                of Chief Financial Officer pursuant to 18
                U.S.C. Section 1350, as adopted pursuant to Section 302 of the
                Sarbanes-Oxley Act of 200232.1
            Certification
                of Chief Executive Officer and Chief
                Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted
                pursuant
                to Section 906 of the Sarbanes-Oxley Act of
                2002





**(1)**
            Previously
                included as an exhibit to the Registration Statement on Form SB-2
                filed on
                February 5, 2007





15
 Table
          of Contents





**SIGNATURES**





In
      accordance with the requirements of the Securities and Exchange Act of 1934,
      the
      Registrant has duly caused this report to be signed on its behalf by the
      undersigned, thereunto duly authorized.





**RM
                  Health International, Inc.**Date:
              July
                  2, 2007By:       /s/ Randy
                  Weston
                Randy
                  Weston
                Title:****Chief
                  Executive Officer, Chief Financial Officer, Principal Accounting
                  Officer
                  and Director